Year: 2018

23
October 2018
Enterome signs global licensing, co-development and co-promotion agreement with Takeda for the treatment of Crohn’s disease
Read more
02
August 2018
Enterome CEO to present at two upcoming investor conferences in the United States
Read more
20
June 2018
Enterome to participate in the 2018 Microbiome Movement – Drug Development Summit in Boston
Read more
04
June 2018
Enterome to attend the Jefferies 2018 Global Healthcare Conference in New York
Read more
01
June 2018
Enterome to Feature Promising Phase 1 clinical data with its Lead Candidate EB8018 for Crohn’s Disease at the Digestive Disease Week 2018
Read more
04
January 2018
Enterome raises €32 million ($38.5 million) in a Series D financing
Read more

Enterome France

Headquarters
94/96 avenue Ledru-Rollin 75011 Paris – France
Tel: +33 (0)1 75 77 27 85
Lab facilities
Biocluster Genopole
5 rue Henri Desbruères – 91030 Evry Cedex